The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $7,625.80 to AmerisourceBergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, is for the supply of the medical product "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" and is scheduled for completion by December 27, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Generated 3/27/25, 9:53 AM